Health Condition 1: J22- Unspecified acute lower respiratory infection
Conditions
Interventions
Intervention1: Kafnorm Syrup: Relief from dry or productive cough
Route of administration: oral
Frequency:10 mLThrice a day
Dose:10mL
Control Intervention1: NOT APPLICABLE: NOT APPLICABLE
Sponsors
Virgo UAP Pharma Pvt
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18â??50 completed years. 2. History of acute dry or productive cough 3. Cough score of 0,1,2 as per day time cough scale. 4. Willing to give written informed consent. 5. Able to comply with study requirements. 6. Female participants of child bearing potential and male participants whose partner is of child bearing potential must be willing to ensure that they or their partner use effective contraception during the study. 7. Patient willing to refrain from smoking, alcohol, etc.
Exclusion criteria
Exclusion criteria: 1. Age 2. Pregnant (as per urine pregnancy test) or lactating female patient. 3. Past history of drug abuse and alcohol consumption since last 6 months. 4. Symptoms of the cough for more than 1 week. 5. Known immune deficiency. 6. Lung disease (include asthma or COPD). 7. Other respiratory disorders like Tuberculosis, chronic bronchitis, asthma, suspected pneumonia, suspected bacterial infections etc. 8. History / current condition of Cardiac disease like cardiomegaly, myocardial infraction, mitral regurgitation etc. 9. Gastrointestinal symptoms such as nausea, vomiting, abdominal pain or diarrhea. 10. Difficulty in filling in the patient diary. 11. History of uncontrolled Diabetes Mellitus. 12. Current smoker, Smoking history >10 packs per month. 13. Patient who received other medications and antibiotic (give all details) for cough within 3 days prior to Investigation drug administration. 14. History of or patients taking any medication that causes cough. 15. History of homemade therapy and patient not willing to refrain from such medications, therapy, home-made therapy during the treatment phase. 16. Patient agreed to avoid such condition like certain foods like cold foods, cold drinks, cough induced lifestyle and cold environmental conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in day and night frequencies of cough: [Time frame: Baseline/Screening & 1, 2 & 3 days post-treatment] â?? Will be evaluated on 6 point scale in treated patient. 1. Change in throat irritation: [Time frame: Baseline/Screening & 1, 2 & 3 days post-treatment] â?? Will be evaluated on 6 point scale.Timepoint: 5 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Duration of relief from symptoms 2. Time to relief from cough and throat irritation 3. Physicianâ??s global assessment of efficacyTimepoint: 5 days | — |
Countries
India
Contacts
Public ContactDr Narsinh M Patel
Sanjeevani Heart And Medical Hospital
Outcome results
None listed